GlassScriptPhysician profile
Audrey L Parmar
NPI 1578953444
$1,044.91
in general payments reported to CMS, 2019-2025
16 companies · $103 in 2025
The $103 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $179 · 2021: $109 · 2022: $48.62 · 2023: $237 · 2024: $138 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $212.52 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Pfizer INC. | $185.71 | 2019-2023 | |
| Genentech USA, INC. | $115.43 | 2023 | Vabysmo |
| Glaxosmithkline, LLC. | $82.23 | 2021-2023 | Bexsero |
| Ironshore Pharmaceuticals INC. | $72.90 | 2020-2024 | |
| Sobi, INC | $72.57 | 2019-2020 | |
| Sanofi Pasteur INC. | $59.72 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $49.38 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $36.85 | 2025 | Jornay Pm |
| Phadia US INC. | $31.31 | 2019-2023 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $30.08 | 2020 | |
| Vertical Pharmaceuticals, LLC | $28.70 | 2025 | Relexxii |
| Ultragenyx Pharmaceutical INC. | $21.90 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.36 | 2025 | Zoryve |
| Shire North American Group INC | $13.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Parmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.